January 10, 2012
A New York federal judge on Tuesday allowed a former U.S. subsidiary of a Chinese vitamin C manufacturer to exit a multidistrict litigation, finding there was no evidence that the unit was involved in a conspiracy to fix domestic prices of the vitamin.